Attributes | Values |
---|
rdf:type
| |
Description
| - CA 15-3 je nádorový ukazatel, který je často indikován a testován, zvláště pak jako součást léčby rakoviny prsu. V naší studii hodnotíme diagnostickou efektivnost tohoto testování a taktéž analytickou reakci osmi dalších imunosetů obvykle používaných k determinaci CA 15-3 v séru: šest uzavřených automatizovaných systémů (AxSYM, Centaur, ECi Vitros, Elecsys 2010, Immulite 2000 a Kryptor) a též dva IRMA sety (ELSA CIS a IRMA-mat Byk-Sangtec). (cs)
- CA 15-3 is a tumour marker that is frequently indicated and examined, particularly as part of breast cancer treatment. In our study we evaluate the diagnostic effectivenes of the examination and also the analytical response of eight routinely employed immunoassay sets for the determination of CA 15-3 in serum: six closed automated systems (AxSYM, Centaur, ECi Vitros, Elecsys 2010, Immulite 2000 and Kryptor), and two IRMA kits (ELSA CIS and IRMA-mat Byk-Sangtec).
- CA 15-3 is a tumour marker that is frequently indicated and examined, particularly as part of breast cancer treatment. In our study we evaluate the diagnostic effectivenes of the examination and also the analytical response of eight routinely employed immunoassay sets for the determination of CA 15-3 in serum: six closed automated systems (AxSYM, Centaur, ECi Vitros, Elecsys 2010, Immulite 2000 and Kryptor), and two IRMA kits (ELSA CIS and IRMA-mat Byk-Sangtec). (en)
|
Title
| - CA 15-3: účinnost esejí a srovnatelnost analytických postupů (cs)
- CA 15-3: The Assay Effectiveness and Comparability of Analytical Procedures
- CA 15-3: The Assay Effectiveness and Comparability of Analytical Procedures (en)
|
skos:prefLabel
| - CA 15-3: účinnost esejí a srovnatelnost analytických postupů (cs)
- CA 15-3: The Assay Effectiveness and Comparability of Analytical Procedures
- CA 15-3: The Assay Effectiveness and Comparability of Analytical Procedures (en)
|
skos:notation
| - RIV/00216208:11150/03:00004206!RIV08-MSM-11150___
|
http://linked.open.../vavai/riv/strany
| |
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00216208:11150/03:00004206
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - Assay; Effectiveness; Comparability; Analytical; Procedures (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - Klinická biochemie a metabolismus
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| |
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |